Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma | Scientific Reports
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Premium Photo | Pivka ii or protein induced by vitamin k ii test a screening marker for hepatocellular carcinoma
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram
Elecsys® PIVKA-II
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma | PLOS ONE
Outcomes of patients presenting with elevated tumor marker levels but negative gadoxetic acid-enhanced liver MRI after a complete response to hepatocellular carcinoma treatment | PLOS ONE
PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma | PLOS ONE
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Distribution and levels of PIVKA-II in all PIVKA-II (+) enrolled... | Download Scientific Diagram
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II - ScienceDirect
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor dif
Frontiers | Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Clinical course of the patient. a Tumor markers (AFP, PIVKA-II)... | Download Scientific Diagram
IJMS | Free Full-Text | Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma
Elecsys® PIVKA-II
Pivka-II Monoclonal Antibody (DCP tumor marker) - China Pivka-II, Antibody | Made-in-China.com
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma - Clinical Laboratory int.
